Introduction: Considering the high prevalence of congenital hypothyroidism (CH) in Isfahan, it seems that it is necessary to investigate the aetiology of the disorder and its related factors. The aim of this study was to...
Acromegaly is characterized not only by disabling symptoms, but also by relevant co-morbidities. Insulin resistance, leading to glucose intolerance is one of the most important contributory factors to the cardiovascular...
A case of POF in a 31-year-old woman with karyotype 47,XXX. The aim of the study was to discuss a case of POF in a 31-year-old patient with polysomy 47,XXX. The described karyotype is not usually associated with this cha...
Alicja Macke-Nauman (2009). Relacja z Konferencji-Kursu: "Wpływ hormonów na układ kostny. Aspekty molekularne i kliniczne".. Endokrynologia Polska, 60(5),
424-425. https://europub.co.uk/articles/-A-85120
Sign In Europub
For faster login or register use your social account.
Relacja z Konferencji-Kursu: "Wpływ hormonów na układ kostny. Aspekty molekularne i kliniczne".
Sonographic assessment of congenitally hypothyroid children in Iran.
Introduction: Considering the high prevalence of congenital hypothyroidism (CH) in Isfahan, it seems that it is necessary to investigate the aetiology of the disorder and its related factors. The aim of this study was to...
Abnormalities in glucose homeostasis in acromegaly. Does the prevalence of glucose intolerance depend on the level of activity of the disease and the duration of the symptoms?
Acromegaly is characterized not only by disabling symptoms, but also by relevant co-morbidities. Insulin resistance, leading to glucose intolerance is one of the most important contributory factors to the cardiovascular...
A case of premature ovarian failure (POF) in a 31-year-old woman with a 47,XXX karyotype.
A case of POF in a 31-year-old woman with karyotype 47,XXX. The aim of the study was to discuss a case of POF in a 31-year-old patient with polysomy 47,XXX. The described karyotype is not usually associated with this cha...
Wpływ leczenia biologicznego na metabolizm kostny chorych na reumatoidalne zapalenie stawów i zesztywniajace zapalenie stawów kregosłupa.